Skip to content

Efficacy of the combination of low-dose dexmedetomidine and esketamine in cesarean section surgery

Efficacy of the combination of low-dose dexmedetomidine and esketamine in cesarean section surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088820
Enrollment
Unknown
Registered
2024-08-27
Start date
2024-10-11
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section

Interventions

Esketamine group:Saline 20 ml micro pumping 10 minutes followed by intravenous push of 0.25 mg/kg esketamine.
Dexmedetomidine combined with esketamine group:Dexmedetomidine 0.5ug/kg diluted to 20ml micropumped 10 minutes followed by intravenous push of 0.25mg/kg esketamine.

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women over 18 years old 2. Full-term singleton pregnancy 3. Planned cesarean section under spinal anesthesia 4. Agree to participate in this study and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. BMI>27 kg/m^2 2. Previous mental disease, central nervous system disease, liver and kidney dysfunction, cardiopulmonary dysfunction, diabetes, or ASA>Grade III 3. Serious obstetric complications such as preeclampsia and eclampsia, gestational hypertension, placenta previa or placental abruption 4. Stillbirth or neonatal malformation 5. Contraindications for spinal anesthesia, including coagulation dysfunction, anticoagulant therapy, severe hypovolemia or hemodynamic instability 6. Unable to cooperate with researchers for any reason, such as hearing or visual impairments, language comprehension difficulties, etc 7. Known history of allergies and contraindications to the investigational drug 8. Heart rate below 50 beats per minute, presence of abnormal cardiac conduction or rhythm, such as sick sinus syndrome and preoperative hypotension (defined as systolic blood pressure<90 mm Hg)

Design outcomes

Primary

MeasureTime frame
Neuropsychiatric symptoms associated with esketamine;

Secondary

MeasureTime frame
Incidence of intraoperative adverse events;Intraoperative maternal satisfaction score;Additional postoperative analgesics;Postoperative pain score;EPDS Rating;Insomnia Severity Index (ISI);Time to first postoperative anal defecation;Postoperative lactation time;Length of postoperative hospitalization;

Countries

China

Contacts

Public ContactXuesheng Liu

Department of Anesthesiology, The First Afliated Hospital of Anhui Medical University

liuxuesheng@ahmu.edu.cn+86 186 5519 3385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026